Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
David Hung
Biotech
David Hung, ex-Medivation execs join forces
David Hung, M.D. is getting back into cancer with his new oncology startup.
Ben Adams
Oct 28, 2019 8:50am
Axovant CEO Hung resigns, along with a host of others
Feb 12, 2018 7:25am
Hung out to dry? Axovant’s terrible JPM week
Jan 10, 2018 5:43am
Axovant slumps as it dumps lead drug intepirdine
Jan 8, 2018 9:55am
Axovant serves up another failed Alzheimer’s med
Sep 26, 2017 7:18am
Chutes & Ladders—Medivation founder Hung takes helm at Axovant
Apr 13, 2017 3:11pm
